ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Interview

Singapore's GIC wary of vaccine optimism amid market boom

Investment chief expects recovery in 2021 and easing in US-China tensions

GIC invests globally, with the U.S., Asia and Europe accounting for 34%, 32% and 19% of its assets, respectively.   © Reuters

SINGAPORE -- While the global economy is expected to rebound from the COVID-19 pandemic in 2021 and stock markets are already heating up, Singapore state fund GIC -- one of the world's biggest institutional investors -- is keeping to a watchful stance on the market outlook.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more